Citation Impact
Citing Papers
A BOILED‐Egg To Predict Gastrointestinal Absorption and Brain Penetration of Small Molecules
2016 Standout
The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications
2011
Topological control of cytokine receptor signaling induces differential effects in hematopoiesis
2019 StandoutScienceNobel
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
Effector Caspases and Leukemia
2011
Engineering precision nanoparticles for drug delivery
2020 Standout
Lymphangiogenesis and cancer metastasis
2002 Standout
Essential Thrombocythemia Associated With Germline JAK2 G571S Variant and Somatic CALR Type 1 Mutation
2016
CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014
2017 Standout
Different biology and clinical outcome according to the absolute numbers of clonal B‐cells in monoclonal B‐cell lymphocytosis (MBL)
2010
Critical oncogenic mutations in newly diagnosed pediatric diffuse intrinsic pontine glioma
2011
Follicular lymphoma-like B cells of uncertain significance (in situ follicular lymphoma) may infrequently progress, but precedes follicular lymphoma, is associated with other overt lymphomas and mimics follicular lymphoma in flow cytometric studies
2013
The DLEU2/miR-15a/16-1 Cluster Controls B Cell Proliferation and Its Deletion Leads to Chronic Lymphocytic Leukemia
2010
Gene panel sequencing improves the diagnostic work-up of patients with idiopathic erythrocytosis and identifies new mutations
2016 StandoutNobel
Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management
2010
Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives
2011
The multilayered complexity of ceRNA crosstalk and competition
2014 StandoutNature
Targeted blocking of miR328 lysosomal degradation with alkalized exosomes sensitizes the chronic leukemia cells to imatinib
2019
Metazoan MicroRNAs
2018 Standout
Monoclonal B cell lymphocytosis in hepatitis C virus infected individuals
2010
Cell biology of tissue factor, the principal initiator of blood coagulation
1996
Caspase Functions in Cell Death and Disease
2013 Standout
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
2017 Standout
Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3): A Marker of Vascular Tumors with Presumed Lymphatic Differentiation, Including Kaposi's Sarcoma, Kaposiform and Dabska-Type Hemangioendotheliomas, and a Subset of Angiosarcomas
2000
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
2014 Standout
Disseminated Intravascular Coagulation
1999 Standout
Exosomal Secretion of Cytoplasmic Prostate Cancer Xenograft-derived Proteins
2009
Alternative transcription and alternative splicing in cancer
2012
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
The role of MicroRNAs in human cancer
2016 Standout
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015
2018 Standout
JAK2 activation by growth hormone and other cytokines
2015
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
2013 Standout
Isolated central nervous system relapse in two patients with BCR-ABL-positive acute leukemia while receiving a next-generation tyrosine kinase inhibitor.
2015
2016 US lymphoid malignancy statistics by World Health Organization subtypes
2016 Standout
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014–2018
2021 Standout
Monoclonal B-cell lymphocytosis in healthy blood donors: an unexpectedly common finding
2013
Should myeloid and lymphoid neoplasms with PCM 1‐JAK 2 and other rearrangements of JAK 2 be recognized as specific entities?
2014
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016
2019 Standout
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
2015 Standout
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Multiple Click-Selective tRNA Synthetases Expand Mammalian Cell-Specific Proteomics
2018 StandoutNobel
Increased frequency (12%) of circulating chronic lymphocytic leukemia–like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach
2009
Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLL
2013
Works of Wanlong Ma being referenced
Proteasome Enzymatic Activities in Plasma as Risk Stratification of Patients with Acute Myeloid Leukemia and Advanced-Stage Myelodysplastic Syndrome
2009
Mutation Profile of JAK2 Transcripts in Patients with Chronic Myeloproliferative Neoplasias
2008
JAK2 Exon 14 Deletion in Patients with Chronic Myeloproliferative Neoplasms
2010
B-Cell Clones as Early Markers for Chronic Lymphocytic Leukemia
2009
Enzymatic activity of circulating proteasomes correlates with clinical behavior in patients with chronic lymphocytic leukemia
2008
Resistance to imatinib in patients with chronic myelogenous leukemia and the splice variant BCR-ABL1 35INS
2016
Differential Diagnosis of Hematologic and Solid Tumors Using Targeted Transcriptome and Artificial Intelligence
2022
BCR-ABL Truncation due to Premature Translation Termination as a Mechanism of Resistance to Kinase Inhibitors
2009
BCR-JAK2 fusion as a result of a translocation (9;22)(p24;q11.2) in a patient with CML-like myeloproliferative disease
2012
Effects of Clinically Relevant MPL Mutations in the Transmembrane Domain Revealed at the Atomic Level through Computational Modeling
2011
BCR-ABLalternative splicing as a common mechanism for imatinib resistance: evidence from molecular dynamics simulations
2008